Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase.
Orlandella FM, Mariniello RM, Mirabelli P, De Stefano AE, Iervolino PLC, Lasorsa VA, Capasso M, Giannatiempo R, Rongo M, Incoronato M, Messina F, Salvatore M, Soricelli A, Salvatore G. Orlandella FM, et al. Among authors: capasso m. Br J Cancer. 2020 Aug;123(3):426-437. doi: 10.1038/s41416-020-0884-9. Epub 2020 May 18. Br J Cancer. 2020. PMID: 32418991 Free PMC article.
Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma.
Totaro F, Cimmino F, Pignataro P, Acierno G, De Mariano M, Longo L, Tonini GP, Iolascon A, Capasso M. Totaro F, et al. Among authors: capasso m. PLoS One. 2013 Oct 21;8(10):e76810. doi: 10.1371/journal.pone.0076810. eCollection 2013. PLoS One. 2013. PMID: 24204677 Free PMC article.
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
Lasorsa VA, Formicola D, Pignataro P, Cimmino F, Calabrese FM, Mora J, Esposito MR, Pantile M, Zanon C, De Mariano M, Longo L, Hogarty MD, de Torres C, Tonini GP, Iolascon A, Capasso M. Lasorsa VA, et al. Among authors: capasso m. Oncotarget. 2016 Apr 19;7(16):21840-52. doi: 10.18632/oncotarget.8187. Oncotarget. 2016. PMID: 27009842 Free PMC article.
BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma.
Sime W, Niu Q, Abassi Y, Masoumi KC, Zarrizi R, Køhler JB, Kjellström S, Lasorsa VA, Capasso M, Fu H, Massoumi R. Sime W, et al. Among authors: capasso m. Cell Death Dis. 2018 May 1;9(5):458. doi: 10.1038/s41419-018-0500-6. Cell Death Dis. 2018. PMID: 29686263 Free PMC article.
Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease.
Esposito MR, Binatti A, Pantile M, Coppe A, Mazzocco K, Longo L, Capasso M, Lasorsa VA, Luksch R, Bortoluzzi S, Tonini GP. Esposito MR, et al. Among authors: capasso m. Int J Cancer. 2018 Nov 15;143(10):2525-2536. doi: 10.1002/ijc.31748. Epub 2018 Sep 17. Int J Cancer. 2018. PMID: 29992558 Free article.
Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.
Cimmino F, Avitabile M, Diskin SJ, Vaksman Z, Pignataro P, Formicola D, Cardinale A, Testori A, Koster J, de Torres C, Devoto M, Maris JM, Iolascon A, Capasso M. Cimmino F, et al. Among authors: capasso m. Int J Cancer. 2018 Dec 1;143(11):2828-2837. doi: 10.1002/ijc.31822. Epub 2018 Oct 4. Int J Cancer. 2018. PMID: 30132831 Free PMC article.
373 results